Legend Capital, one of conglomerate Legend Holdings' investment units, has co-led a series B round for medical device supply chain services provider Guoke Hengtai.
China-based supply chain services provider Guoke Hengtai Medical Technology has raised tens of millions of renminbi (RMB10m = $1.5m) in a series B round co-led by conglomerate Legend, China Money Network reported today.
Legend participated through its Legend Capital division and co-led the round with Cash Capital Investment Management, the investment arm of the state-owned Chinese Academy of Sciences Holdings.
Insurance company Aeon Life reportedly also participated in the round, as did Northern Light Venture Capital, Frontline Bioventures and Blue…
